At the start of 2023, the “tripledemic” waned, with number of infections and hospitalizations on the decline. As infection rates stabilize, the demand for analgesics is expected to return to normal.
While CBD has emerged as a trendy ingredient within the beauty and food space over the past few years, its status among consumer health companies remains in limbo. Currently, the only FDA-approved drug containing CBD, Epidiolex, is used to treat two rare and severe forms of epilepsy.
US consumers are becoming more educated about pain relief, and feel increasingly confident managing their pain. This is sometimes through embracing wellness as a whole, with a more ‘natural’ approach to pain management which involves lifestyle adjustment, a better diet, meditation and yoga.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Understand the latest market trends and future growth opportunities for the Analgesics industry in USA with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in USA, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).See All of Our Definitions
This report originates from Passport, our Analgesics research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!